SENP5 Activators are compounds that modulate the activity of the enzyme SENP5 (Sentrin/SUMO-specific protease 5). SENP5 is part of a family of proteases that are involved in the post-translational modification process known as SUMOylation, which is the covalent attachment of Small Ubiquitin-like Modifier (SUMO) proteins to target substrates. SENP5 in particular has a predilection for processing pre-SUMO or for the deconjugation of SUMO from target proteins, thereby regulating their function. The modulation of SENP5 activity by its activators can therefore play a significant role in controlling the SUMOylation status of proteins, influencing numerous cellular processes including genomic stability, transcription, DNA repair, and cell cycle progression.
SENP5 Activators are typically small molecules. These compounds interact with SENP5 at specific sites, which may induce conformational changes that enhance the enzyme's catalytic efficiency or substrate specificity. The exact mechanism of action for these activators would depend on their structure and the nature of their interaction with SENP5. For instance, an activator might bind to the active site of SENP5 and facilitate the cleavage of SUMO from substrates, or it might stabilize the enzyme in an active conformation that is more efficient at processing SUMO precursors. Through these actions, SENP5 Activators can modulate the dynamic process of SUMOylation and thus impact the functions of a variety of cellular proteins. These compounds serve as critical tools for dissecting the SUMO pathway and understanding the role of SENP5 in maintaining cellular homeostasis. By manipulating SENP5 activity, scientists can investigate the consequences of altered SUMOylation patterns on cellular physiology and gain insights into the intricate regulation of protein functions by this essential post-translational modification.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Anacardic Acid | 16611-84-0 | sc-202463 sc-202463A | 5 mg 25 mg | $100.00 $200.00 | 13 | |
Anacardic Acid is a histone acetyltransferase inhibitor which, by altering chromatin structure and gene expression, could increase the accessibility of substrates to SENP5, enhancing its activity. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
MG132 is a proteasome inhibitor that could lead to the accumulation of poly-SUMOylated proteins, potentially increasing the demand for and activity of SENP5 in desumoylation processes. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Chloroquine, by inhibiting lysosomal activity, may increase the levels of SUMOylated proteins, indirectly necessitating greater SENP5 activity for protein deconjugation. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Resveratrol, a SIRT1 activator, could enhance SENP5 activity by deacetylating and activating transcription factors that increase the expression of proteins requiring desumoylation by SENP5. | ||||||
Spermidine | 124-20-9 | sc-215900 sc-215900B sc-215900A | 1 g 25 g 5 g | $56.00 $595.00 $173.00 | ||
Spermidine, by inducing autophagy, may indirectly enhance SENP5 activity by modulating the turnover of proteins and increasing the requirement for SENP5-mediated desumoylation. | ||||||
Ubiquitin E1 Inhibitor, PYR-41 | 418805-02-4 | sc-358737 | 25 mg | $360.00 | 4 | |
Pyr-41 is a ubiquitin-activating enzyme E1 inhibitor, which could indirectly enhance SENP5 activity by stabilizing poly-SUMO chains and increasing desumoylation requirements. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A, as an HDAC inhibitor, may enhance SENP5 activity by increasing the acetylation of proteins and altering their interaction with SUMO, thereby affecting SENP5's substrate profile. | ||||||
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $134.00 $215.00 $440.00 $496.00 | 19 | |
Epoxomicin is another proteasome inhibitor that may lead to an accumulation of SUMOylated proteins, thereby potentially enhancing the activity of SENP5 in response to increased load. | ||||||
Withaferin A | 5119-48-2 | sc-200381 sc-200381A sc-200381B sc-200381C | 1 mg 10 mg 100 mg 1 g | $127.00 $572.00 $4090.00 $20104.00 | 20 | |
Withaferin A, an inhibitor of nuclear factor kappa B (NF-kB) activation, may enhance SENP5 activity by modulating the SUMOylation status of NF-kB and associated proteins. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $38.00 $58.00 $102.00 $202.00 | 8 | |
Geldanamycin, an Hsp90 inhibitor, may enhance SENP5 activity by disrupting the maturation of SUMOylated client proteins, increasing the requirement for desumoylation by SENP5. | ||||||